使用抗 Xa 监测的依诺肝素预防静脉血栓栓塞的临床效果

IF 2.9 3区医学 Q2 PHARMACOLOGY & PHARMACY

Pharmacotherapy Pub Date : 2023-12-13 DOI:10.1002/phar.2900

John A. Saunders, Sara R. Vazquez, Joseph A. Hill, Daniel M. Witt

引用次数: 0

摘要

大多数接受低分子肝素治疗的患者不需要常规凝血监测，但由于某些人群的不确定性，临床医生可能会感到有必要进行抗xa监测。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Clinical outcomes associated with anti-Xa-monitored enoxaparin for venous thromboembolism prophylaxis

Most patients receiving Low-molecular-weight heparin therapy do not require routine coagulation monitoring, but due to uncertainty in certain populations, clinicians may feel compelled to perform anti-Xa monitoring.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Pharmacotherapy 医学-药学

CiteScore

7.80

自引率

2.40%

发文量

审稿时长

4-8 weeks

期刊介绍： Pharmacotherapy is devoted to publication of original research articles on all aspects of human pharmacology and review articles on drugs and drug therapy. The Editors and Editorial Board invite original research reports on pharmacokinetic, bioavailability, and drug interaction studies, clinical trials, investigations of specific pharmacological properties of drugs, and related topics.